Dec. 6, 2002 – Protiveris Inc., a Maryland-based developer of bioMEMS technology for protein research and drug discovery, said it has appointed a new management team.
Appointments include Robert Menzi as chief operating officer and Sebastian Kossek as chief scientific officer. Menzi previously served as Protiveris’ vice president of finance, and before that he was part of the corporate development staff at Raytheon Co. Kossek had been a biosensor researcher at the Paul Scherrer Institut in northern Switzerland, and served in management positions at Molecular Imaging.